Cytoskeletal signaling inhibitors affect the structural framework of cells. They have applications in cancer and other diseases where cell shape and motility are critical factors. By interfering with the cytoskeleton, these inhibitors can impede the invasive properties of cancer cells and offer new avenues for treatment.
